Patients Discontinuing Weight-Loss Medications Gain Back Weight Far More Rapidly Than Dieters

Fresh analysis reveals that individuals who come off new slimming jabs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who stop conventional diet and exercise plans.

Published data in a major medical journal demonstrates that while overweight individuals can lose about a fifth of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Individuals using these drugs should be aware of the danger of fast rebound weight gain when the treatment is stopped," stated expert Dr. Susan Jebb.

This pace of recovery means a reversion to starting mass in about a year and a half.

Analyzing Approaches

The study, which reviewed dozens of studies involving over 9,000 of participants, compared the results of the injectable medications with conventional dieting.

Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically see a less rapid weight regain—perhaps 0.1 kg a month—once they finish.

Explaining the Quick Rebound

Doctors suggest the mechanism of the injections is key to understanding the amplified rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making binge eating a significant risk."

A Lifelong Disease?

Health authorities suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, due to the high risk of relapse, the treatment is often life-long.

This perspective is reinforced by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," comparing it to managing diseases like high blood pressure.

Patient Experiences

People who have discontinued the medication report a powerful return of hunger.

"It was like a switch that goes on and you become extremely hungry," recalled an individual.

This challenge is exacerbated if individuals have not established sustainable dietary or behavioural modifications during therapy.

Widespread Adoption

Recent estimates suggest that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Adoption is higher among females than men.
• The 40s and 50s demographic shows the greatest usage rates.
• Many access the medications through private healthcare rather than public health services.

In conclusion, clinicians emphasize that while these medications are effective tools for shedding pounds, they are not a magic solution and long-term success relies on combined behavioural support.